PCMC
BMY icon

Planning Capital Management Corporation’s Bristol-Myers Squibb BMY Stock Holding History

Planning Capital Management Corporation’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$140K Sell
2,698
-615
-19% -$28.9K 0.09% 109
2024
Q2 		$138K Hold
3,313
– – 0.1% 112
2024
Q1 		$180K Hold
3,313
– – 0.13% 91
2023
Q4 		$170K Buy
+3,313
New +$174K 0.13% 92

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Planning Capital Management Corporation's BMY Position: Q3 2024 in Review

Planning Capital Management Corporation reduced its Bristol-Myers Squibb (BMY) stake by 19% in Q3 2024, selling an estimated $28.9K and leaving 2,698 shares worth $140K. The position accounts for 0.09% of the portfolio, ranked #109.

Planning Capital Management Corporation first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $180K in Q1 2024. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Planning Capital Management Corporation held 2,698 shares of Bristol-Myers Squibb worth $140K as of Q3 2024.
  • Planning Capital Management Corporation sold 615 Bristol-Myers Squibb shares in Q3 2024, an estimated $28.9K.
  • Bristol-Myers Squibb made up 0.09% of Planning Capital Management Corporation's portfolio in Q3 2024, its #109 holding.
  • Planning Capital Management Corporation first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
  • Planning Capital Management Corporation's Bristol-Myers Squibb position peaked at $180K in Q1 2024.
  • 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Planning Capital Management Corporation's 13F filing for Q3 2024, filed 6 Nov 2024.